Cyclosporine 0.05% Eye Drops for Vernal Keratoconjunctivitis Trial
Status:
Completed
Trial end date:
2021-06-01
Target enrollment:
Participant gender:
Summary
To observe and compare the clinical efficacy of cyclosporine 0.05% eye drops with Loteprednol
Etabonate 0.5% and Tobramycin Eye Drops 0.3% in the treatment of Vernal Keratoconjunctivitis
in developing regions of China.